Vfend and Bumetanide drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Vfend (voriconazole) and Bumetanide (bumetanide). Common drug interactions include hypotension among females and pneumonia among males.

The phase IV clinical study analyzes what interactions people have when they take Vfend and Bumetanide. It is created by eHealthMe based on reports of 17 people who take the same drugs from the FDA, and is updated regularly.

What is Vfend?

Vfend has active ingredients of voriconazole. It is often used in aspergillosis. eHealthMe is studying from 12,128 Vfend users. Check the latest studies of Vfend.

What is Bumetanide?

Bumetanide has active ingredients of bumetanide. It is often used in fluid retention. eHealthMe is studying from 20,532 Bumetanide users. Check the latest studies of Bumetanide.



On Jul, 13, 2026

17 people who take Vfend and Bumetanide together, and have interactions are studied.

Vfend and Bumetanide drug interactions.

What are the common drug interactions of Vfend and Bumetanide, by gender? *:

female:

  1. Hypotension (abnormally low blood pressure)
  2. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  3. Device related infection
  4. Fungaemia (fungi circulate in the blood)
  5. Fungal infection
  6. Hiatus hernia (hernia resulting from the protrusion of part of the stomach through the diaphragm)
  7. Memory impairment
  8. Mitral valve disease (disease of mitral valve of heart)
  9. Oesophageal disorder (disease of oesophagus)
  10. Pneumonia aspiration (bronchopneumonia that develops due to the entrance of foreign materials into the bronchial tree)

male:

  1. Pneumonia
  2. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  3. Blood creatinine increased
  4. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  5. Death
  6. Multi-organ failure (multisystem organ failure)
  7. Renal failure (kidney dysfunction)
  8. Renal failure acute (rapid kidney dysfunction)
  9. Renal insufficiency (insufficient excretion of wastes by the kidneys)
  10. Septic shock (shock due to blood infection)

What are the common drug interactions of Vfend and Bumetanide, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Blood creatinine increased
  2. Multi-organ failure (multisystem organ failure)
  3. Renal insufficiency (insufficient excretion of wastes by the kidneys)

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Viral infection

60+:

  1. Pneumonia
  2. Hypotension (abnormally low blood pressure)
  3. Memory impairment
  4. Mitral valve disease (disease of mitral valve of heart)
  5. Oesophageal disorder (disease of oesophagus)
  6. Pneumonia aspiration (bronchopneumonia that develops due to the entrance of foreign materials into the bronchial tree)
  7. Tachycardia (a heart rate that exceeds the range of 100 beats/min)
  8. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  9. Bronchial secretion retention
  10. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)

What are the existing conditions these people have? *

  1. Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 6 people, 35.29%
  2. Fungal Infection: 5 people, 29.41%
  3. Nausea (feeling of having an urge to vomit): 4 people, 23.53%
  4. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 4 people, 23.53%
  5. Back Pain: 4 people, 23.53%
  6. Bone Pain: 4 people, 23.53%
  7. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 4 people, 23.53%
  8. High Blood Pressure: 4 people, 23.53%
  9. Joint Pain: 4 people, 23.53%
  10. Oedema (fluid collection in tissue): 4 people, 23.53%

* Approximation only. Some reports may have incomplete information.

Do you take Vfend and Bumetanide?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Vfend and Bumetanide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Vfend:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Bumetanide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Vfend and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Bumetanide and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on voriconazole and bumetanide (the active ingredients of Vfend and Bumetanide, respectively), and Vfend and Bumetanide (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: